Rare diseases
Investigational molecules
Locations
703 conditions with trials, the busiest first
3 898 trials across Europe, recruiting first
Study on Tocotrienol and Bevacizumab for Patients with Metastatic Colorectal Cancer
DenmarkStudy on the Safety of Radiation and Nivolumab for Patients with Esophageal Cancer
NorwayStudy of Vusolimogene Oderparepvec and Nivolumab for Patients with Solid Tumors
FranceStudy on the Effects of Capecitabine and Oxaliplatin in Patients with Locally Advanced Colon Cancer
DenmarkStudy of MaaT013 (Fecal Transplantation) Combined with Ipilimumab and Nivolumab in Patients with Previously Untreated Melanoma
FranceStudy Comparing Avelumab and Standard Chemotherapy for Patients with Metastatic Colorectal Cancer with Microsatellite Instability
FranceStudy of Avutometinib and Defactinib for Patients with Recurrent Low-Grade Serous Ovarian Cancer
BelgiumStudy of Nivolumab for Patients with Esophageal Cancer Undergoing Active Surveillance After Chemoradiation
The NetherlandsStudy on Capecitabine and Oxaliplatin for Patients with High Risk Rectal Cancer
ItalyStudy of Drug Combination Treatment (Capecitabine, Oxaliplatin, Fluorouracil, Irinotecan) Guided by Liquid Biopsy Testing in Patients with Stage III and High-Risk Stage II Colon Cancer
ItalyStudy on the Safety and Effects of Temferon for Patients with Metastatic Renal Cell Carcinoma Using a Drug Combination
ItalyStudy of GEN3014 and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma and Other Blood Cancers
CzechiaThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
